Tff pharmaceuticals announces delisting from nasdaq and potential sec deregistration

Foxborough, mass., feb. 6, 2025 /prnewswire/ -- tff pharmaceuticals, inc. (nasdaq: tffp) today announced that the company has provided notification to the nasdaq stock market, llc ("nasdaq") of its intent to voluntarily delist the company's common stock, par value $0.001 per share (the "common stock"), from the nasdaq capital market.
NDAQ Ratings Summary
NDAQ Quant Ranking